Thavarajah, J. J., Hønge, B. L. & Wejse, C. M. (2024). The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention. Viruses, 16(6), Article 911. https://doi.org/10.3390/v16060911

Christensen, J., Johansen, N. D., Janstrup, K. H., Modin, D., Skaarup, K. G., Nealon, J., Samson, S., Loiacono, M., Harris, R., Larsen, C. S., Jensen, A. M. R., Landler, N. E., Claggett, B. L., Solomon, S. D., Gislason, G. H., Køber, L., Landray, M. J., Sivapalan, P., Jensen, J. U. S. & Biering-Sørensen, T. (2024). Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trial. Journal of Infection, 89(5), Article 106276. https://doi.org/10.1016/j.jinf.2024.106276

Mahr, A. R., Bennett-Boehm, M. M. C., Rothemejer, F. H., Weber, I. S., Regan, A. K., Franzen, J. Q., Bisson, C. R., Truong, A. N., Olesen, R., Schleimann, M. H., Rauter, C. M., Smith, A. L., El-Gamal, D., Søgaard, O. S., Tolstrup, M. & Denton, P. W. (2024). TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity. Scientific Reports, 14(1), Article 14595. https://doi.org/10.1038/s41598-024-65576-2

Dai, Y., Idorn, M., Serrero, M. C., Pan, X., Thomsen, E. A., Narita, R., Maimaitili, M., Qian, X., Iversen, M. B., Reinert, L. S., Flygaard, R. K., Chen, M., Ding, X., Zhang, B. C., Carter-Timofte, M. E., Lu, Q., Jiang, Z., Zhong, Y., Zhang, S. ... Paludan, S. R. (2024). TMEFF1 is a neuron-specific restriction factor for herpes simplex virus. Nature, 632(8024), 383-389. https://doi.org/10.1038/s41586-024-07670-z

Pedersen, O. S., Butova, T., Kapustnyk, V., Miasoiedov, V., Kuzhko, M., Hryshchuk, L., Kornaha, S., Borovok, N., Raznatovska, O., Fedorec, A., Bogomolov, A., Tkhorovskiy, M., Akymenko, O., Klymenko, I., Kulykova, O., Karpenko, Z., Shapoval, T., Chursina, N., Kondratyuk, N. ... Butov, D. (2024). Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine. Clinical Microbiology and Infection, 30(3), 360-367. https://doi.org/10.1016/j.cmi.2023.12.001

Tusch, E., Ryom, L., Pelchen-Matthews, A., Mocroft, A., Elbirt, D., Oprea, C., Günthard, H. F., Staehelin, C., Zangerle, R., Suarez, I., Vehreschild, J. J., Wit, F., Menozzi, M., d'Arminio Monforte, A., Spagnuolo, V., Pradier, C., Carlander, C., Suanzes, P., Wasmuth, J.-C. ... D:A:D cohort study (2024). Trends in Mortality in People With HIV From 1999 through 2020: a multi-cohort collaboration. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 79(5). https://doi.org/10.1093/cid/ciae228

Skouvig Pedersen, O., Barkholt, T. Ø., Horskær Madsen, S. & Rudolf, F. (2024). Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment. BMJ Case Reports, 17(6), Article e259211. https://doi.org/10.1136/bcr-2023-259211

Florescu, S. A., Larsen, C. S., Helleberg, M., Marin, A., Popescu, C. P. & Schlagenhauf, P. (2024). Upsurge in cases of travellers’ malaria ex Zanzibar indicates that malaria is on the rebound in the archipelago. New Microbes and New Infections, 57, Article 101226. https://doi.org/10.1016/j.nmni.2024.101226

Boysen, A. T., Whitehead, B., Revenfeld, A. L. S., Gupta, D., Petersen, T. & Nejsum, P. (2024). Urine-derived stem cells serve as a robust platform for generating native or engineered extracellular vesicles. Stem Cell Research and Therapy, 15(1), Article 288. https://doi.org/10.1186/s13287-024-03903-0

Madsen, A. M. R., Schaltz-Buchholzer, F., Nielsen, S., Benfield, T., Bjerregaard-Andersen, M., Dalgaard, L. S., Dam, C., Ditlev, S. B., Faizi, G., Azizi, M., Hameed, Z. N., Johansen, I. S., Kofoed, P.-E., Krause, T. G., Kristensen, G. S., Loekkegaard, E. C. L., Mogensen, C. B., Mohamed, L., Oedegaard, E. S. ... Benn, C. S. (2024). Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: a randomized controlled trial. The Journal of Infectious Diseases, 229(2), 384-393. https://doi.org/10.1093/infdis/jiad422